As of November 2024, Jafron Biomedical has a market cap of $2.84B. This makes Jafron Biomedical the world's 4117th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.33B | -7.92% |
2023 | $2.54B | -28.22% |
2022 | $3.53B | -41.89% |
2021 | $6.08B | -21.41% |
2020 | $7.73B | 79.37% |
2019 | $4.31B | 73.11% |
2018 | $2.49B | 30.18% |
2017 | $1.91B | -32.26% |
2016 | $2.82B | - |